Alzheimer's disease (AD) is a progressive brain disorder and a leading cause of dementia worldwide. Despite years of research, there…
Researchers at Baylor College of Medicine have uncovered a built in process that can remove existing amyloid plaques from the…
Alzheimer's disease is often described in numbers, with millions of people affected, cases rising quickly, and costs reaching into the…
Alzheimer's disease (AD) remains one of the most pressing global health challenges, especially as aging populations continue to grow. The…
Older adults who carry genes linked to a higher risk of Alzheimer's disease may not experience the expected increase in…
A team led by neurobiologist Prof. Dr. Hilmar Bading at Heidelberg University has identified a key molecular process that drives…
Lecanemab, marketed as Leqembi, is a monoclonal antibody treatment for Alzheimer's disease that targets and removes harmful amyloid plaques while…
Scientists at UCLA Health and UC San Francisco have discovered why certain brain cells are better equipped than others to…
Small shifts in how blood moves through the brain and how brain cells receive oxygen may be closely connected to…
Scientists at Washington University School of Medicine in St. Louis have developed a new way to estimate when a person…